Bulletin
Investor Alert

Roche Holding AG Part. Cert.

OTC: RHHVF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Feb 8, 2023, 3:49 p.m.

/zigman2/quotes/206948568/delayed

$

306.51

Change

-1.26 -0.41%

Volume

Volume 2,104

Quotes are delayed by 20 min

/zigman2/quotes/206948568/delayed

Previous close

$ 307.77

$ 306.51

Change

-1.26 -0.41%

Day low

Day high

$306.51

$314.99

Open

52 week low

52 week high

$298.00

$430.00

Open

Insider Actions for Roche Holding AG Part. Cert.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/19/2022 DIRECTOR Swiss Non EXECUTIVE
610   Acquisition at $328.68 per share. 200,493
05/13/2022 Executive Officer Swiss
1   Acquisition at $319 per share. 319
05/13/2022 Executive Officer Swiss
1   Acquisition at $319 per share. 319
05/13/2022 Executive Officer Swiss
1   Acquisition at $319 per share. 319
05/13/2022 Executive Officer Swiss
1   Acquisition at $319 per share. 319
05/11/2022 Executive Officer Swiss
1,500   Acquisition at $326.78 per share. 490,162
03/30/2022 Executive Officer Swiss
1,624   Disposition at $373.14 per share. 605,971
03/30/2022 Executive Officer Swiss
1,624   Disposition at $373.14 per share. 605,971
12/16/2021 Executive Officer Swiss
19,920   Disposition at $379.95 per share. 7,568,627
12/16/2021 Executive Officer Swiss
19,920   Disposition at $379.95 per share. 7,568,627
12/16/2021 Executive Officer Swiss
19,920   Derivative/Non-derivative trans. at $379.95 per share. 7,568,627
12/16/2021 Executive Officer Swiss
19,920   Derivative/Non-derivative trans. at $379.95 per share. 7,568,627
08/12/2021 Executive Officer Swiss
3,163   Disposition at $368.23 per share. 1,164,698
08/12/2021 Executive Officer Swiss
3,163   Disposition at $368.23 per share. 1,164,698
08/09/2021 Executive Officer Swiss
8,788   Acquisition at $362.2 per share. 3,183,013
08/09/2021 Executive Officer Swiss
8,788   Acquisition at $362.2 per share. 3,183,013
08/09/2021 DIRECTOR Swiss Non EXECUTIVE
271   Acquisition at $394.4 per share. 106,881
08/09/2021 DIRECTOR Swiss Non EXECUTIVE
271   Acquisition at $394.4 per share. 106,881
07/30/2021 Executive Officer Swiss
4,317   Disposition at $350 per share. 1,510,950
07/30/2021 Executive Officer Swiss
1,116   Disposition at $350 per share. 390,600
07/30/2021 Executive Officer Swiss
4,317   Disposition at $350 per share. 1,510,950
07/30/2021 Executive Officer Swiss
1,116   Disposition at $350 per share. 390,600
06/22/2021 Executive Officer Swiss
500   Disposition at $374.8 per share. 187,400
06/22/2021 Executive Officer Swiss
500   Disposition at $374.8 per share. 187,400
06/17/2021 Executive Officer Swiss
3,000   Disposition at $348.6 per share. 1,045,800
06/17/2021 Executive Officer Swiss
2,000   Disposition at $373.13 per share. 746,250
06/17/2021 Executive Officer Swiss
3,000   Disposition at $348.6 per share. 1,045,800
06/17/2021 Executive Officer Swiss
2,000   Disposition at $373.13 per share. 746,250

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
1 Purchases
0 Sales
610
0
Last 12 months
6 Purchases
2 Sales
2,114
3,248

Officers and Executives

Dr. Severin Schwan
Chief Executive Officer & Executive Director
Dr. Alan Hippe
Chief Financial & Information Officer
Dr. Levi A. Garraway
Chief Medical Officer
Dr. Gallia G. Levy
Associate Group Medical Director-Hematology
Ms. Pascale Schmidt
Chief Compliance Officer
Mr. Per-Olof Attinger
Secretary-Executive Committee & Head-CEO Office
Dr. Hans Clevers
Head-Pharma Research & Early Development
Dr. Jemilah Mahmood
Director
Dr. Bruno Eschli
Head-Investor Relations
Ms. Cristina A. Wilbur
Chief People Officer
Dr. Annette Luther
Secretary
Ms. Claudia Boeckstiegel
General Counsel
Dr. Christoph Franz
Chairman
Dr. Joerg Duschmale
Independent Non-Executive Director
Dr. Patrick Frost
Independent Non-Executive Director
Mr. André S. Hoffmann
Vice Chairman
Mr. Bernard J. Poussot
Independent Non-Executive Director
Dr. Richard P. Lifton
Independent Non-Executive Director
Dr. Claudia Süssmuth Dyckerhoff
Independent Non-Executive Director
Ms. Anita Hauser
Independent Non-Executive Director
Link to MarketWatch's Slice.